Advanced Filters
noise

covid-19 Clinical Trials

A listing of covid-19 medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 347 clinical trials
D Damayanti Tinduh, MD

UNAIR Inactivated COVID-19 Vaccine as Homologue Booster (Immunobridging Study)

The goal of this open-label clinical trial is to evaluate the safety and immunogenicity of INAVAC (Vaksin Merah Putih - UNAIR SARS-CoV-2 (Vero Cell Inactivated)) Vaccine as Homologue Booster in Adult Subjects in Indonesia. The main question it aims to answer is: "To evaluate the humoral immunogenicity profile at 28 …

18 years of age All Phase N/A
A Alice Ryan, PhD

Modifying Adiposity Through Behavioral Strategies to Improve COVID-19 Rehabilitation

The research in this VA Merit will examine the effects of obesity and Post-COVID Conditions (PCC) on physical functioning, health-related quality of life, and adipose tissue inflammatory and cellular senescence profiles in older Veterans. Further, it will evaluate whether a weight loss intervention, including dietary modification and exercise, in obese …

55 - 80 years of age All Phase N/A
Z Zhong Lidan, Ph.D, MD

Acupuncture for Post COVID-19 Condition (Long COVID) Neuropsychiatric Symptoms

In this study, a 12-week pragmatic, randomized, double-blinded clinical trial will be conducted to evaluate the efficacy of acupuncture for the treatment of long Covid neuropsychiatric symptoms and provide reference for clinical non-drug treatment.

18 - 80 years of age All Phase N/A
M Maite Garolera, PhD

Digital Multimodal Rehabilitation for People With Post-acute COVID-19 Syndrome.

Although most infected people survive the infection, many have persistent sequelae or symptoms, which cause disability or decreased quality of life. The World Health Organization has called on countries to prioritize the rehabilitation of the consequences of COVID-19 in both the medium and long term, as this chronicity is expected …

18 - 100 years of age All Phase N/A

Efficacy of FES Cycling After a Severe Form of COVID-19

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing the coronavirus disease 2019 (COVID-19) affect at late march 2021 more than 127 millions of persons worldwide (including more than 4.5 millions in France, according to John Hopkins University https://coronavirus.jhu.edu/map.html, consulted 2021/3/25). Among these persons, 17% of the confirmed cases the …

18 years of age All Phase N/A

Effect Of Musıc Therapy On Anxıety Levels In COVID-19 Pandemıc

This study, which has a randomized controlled experimental design, was planned to determine the effect of music therapy on the anxiety level of family health personnel working in primary health care centers during the COVID-19 pandemic. The study will be carried out between 4 August and 31 December with nurses, …

years of age All Phase N/A
M Michael Keller, MD

T CELL THERAPY OPPOSING NOVEL COVID-19 INFECTION IN IMMUNOCOMPROMISED PATIENTS

This is an open label, phase I dose-escalation study to evaluate the safety of coronavirus-specific T cell (CST) therapy for prevention of SARS-CoV-2 infection in immunocompromised patients following hematopoietic stem cell transplantation (HSCT). Participants will receive donor-derived CSTs for prevention of SARS-CoV-2 infection after HSCT (≥28 days and <4 months …

12 - 80 years of age All Phase 1
K Karin J Grimm, MD

Baldachin: Ceiling HEPA-filtration to Prevent Nosocomial Transmission of COVID-19

In this study, a patient space occupied by a patient with confirmed COVID-19 in an open-space multiple bed area in the Intermediate Care Unit will be equipped with a mobile, optimally placed high efficiency particulate air ("HEPA")-equivalent air filtration unit ("Baldachin") in addition to existing hospital policy infection prevention and …

18 - 120 years of age All Phase N/A
L Lauren Harrison, MSN

SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease

The 2019 Severe Acute Respiratory Syndrome (SARS) is a global pandemic secondary to a novel coronavirus - SARS-CoV-2. The reported case-fatality ratio for SARS-CoV-2 in the United States is 1.8% with a current death toll of >300,000 and climbing.4 There is no accepted standard of care or FDA approved therapies …

18 - 65 years of age All Phase 1/2
C Cyndya Shibao, MD, MSCI

Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia Syndrome

The term post-acute COVID-19 syndrome or Long COVID is a disabling syndrome that persists beyond the 3-month convalescence period after COVID-19 infections. This syndrome affects mostly women (~80%), present with chronic tachycardia and Orthostatic intolerance symptoms without any identifiable cause. In addition, non-specific symptoms such as fatigue, headache, and "brain …

18 years of age All Phase N/A

Simplify language using AI